HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies

SIMPLE SUMMARY: There are growing data on targeting HER2 alterations, which include gene mutations, gene amplifications, and protein overexpression, for non-small cell lung cancer (NSCLC). Currently, there are limited targeted therapies approved for NSCLC patients with HER2 alterations, and this rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Uy, Natalie F., Merkhofer, Cristina M., Baik, Christina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454740/
https://www.ncbi.nlm.nih.gov/pubmed/36077691
http://dx.doi.org/10.3390/cancers14174155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454740/
https://www.ncbi.nlm.nih.gov/pubmed/36077691
http://dx.doi.org/10.3390/cancers14174155

Ejemplares similares